Bronte Capital Management Pty Ltd. Q2 2021 Filing

Filed August 9, 2021

Portfolio Value

$1.4T

Holdings

21

Report Date

Q2 2021

Filing Type

13F-HR

All Holdings (21 positions)

#StockSharesValue% PortfolioType
1
IWMISHARES TR
144,400$333.6B23.79%Call
2
SPYSPDR S&P 500 ETF TR
52,300$224.8B16.03%Call
3
IWOISHARES TR
519,500$161.9B11.55%Call
4
GOOGLALPHABET INC-CL A
49,176$120.1B8.56%
5
HLFHERBALIFE NUTRITION LTD
2,253,861$118.8B8.47%
6
BRK/BBERKSHIRE HATHAWAY INC-CL B
423,993$117.8B8.40%
7
REGNREGENERON PHARMACEUTICALS
117,469$65.6B4.68%
8
IBKRINTERACTIVE BROKERS GRO-CL A
852,162$56.0B3.99%
9
VVISA INC-CLASS A SHARES
177,440$41.5B2.96%
10
CTVACORTEVA INC
823,242$36.5B2.60%
11
BKBANK OF NEW YORK MELLON CORP
497,891$25.5B1.82%
12
STTSTATE STREET CORP
268,574$22.1B1.58%
13
GOOGALPHABET INC-CL C
6,972$17.5B1.25%
14
BYNDBEYOND MEAT INC
100,000$15.7B1.12%Put
15
GHCGRAHAM HOLDINGS CO-CLASS B
23,493$14.9B1.06%
16
MOALTRIA GROUP INC
287,561$13.7B0.98%
17
NEMNEWMONT CORP
72,829$4.6B0.33%
18
MDLZMONDELEZ INTERNATIONAL INC-A
69,807$4.4B0.31%
19
MACKEURMERRIMACK PHARMACEUTICALS IN
548,836$3.5B0.25%
20
BNTXBIONTECH SE-ADR
10,963$2.5B0.17%
21
DECIBEL THERAPEUTICS INC
159,462$1.4B0.10%